Mitoxantrone Hydrochloride Liposome Combination Regimen in the Treatment of High-risk/Extramedullary Multiple Myeloma
Clinical trial NCT06246162 · RECRUITING
Trial details
- NCT number
- NCT06246162
- Sponsor
- Affiliated Hospital of Nantong University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-13
- Primary completion
- 2025-11-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.